| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 60560-33-0 | PINACIDIL | p1134 s-1230 PINACIDIL pinacidilmonohydrate N-CYANO-N'-4-PYRIDINYL-N''-(1,2,2-TRIMETHYLPROPYL)GUANIDINE 2-cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)guanidinemonohydrate 2-cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)-guanidinmonohydrate n-cyano-n’-4-pyridinyl-n’’-(1,2,2-trimethylpropyl)-guanidinmonohydrate | ||
| 2 | 60560-07-8 | 3-pyridyl pinacidil | 3-pyridyl pinacidil 2-Cyano-3-(3-pyridyl)-1-(1,2,2-trimethylpropyl)guanidine Guanidine, N-cyano-N'-3-pyridinyl-N''-(1,2,2-trimethylpropyl)- | ||
| 3 | 1206825-36-6 | Tofacitinib Impurity 3 | Tofatinib Impurity 3 Tofacitinib Impurity 3 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-, rel- | ||
| 4 | 2374700-39-5 | Tofacitinib Impurity 44 | Tofacitinib Impurity 44 Azilsartan medoxomil impurity320 | ||
| 5 | 919730-72-6 | N-cyclooctyl-7H-purin-6-amine | N-cyclooctyl-7H-purin-6-amine | ||
| 6 | 6-Cyclohexylamino-9-ethyl-9H-purine | 6-Cyclohexylamino-9-ethyl-9H-purine | |||
| 7 | 2-(2-Adamantylamino)-4-amino-1,3,5-triazine | 2-(2-Adamantylamino)-4-amino-1,3,5-triazine | |||
| 8 | 195252-07-4 | 9H-Purin-6-amine, 9-cyclohexyl-N,N-dimethyl- | 9-Cyclohexyl-N,N-dimethyl-9H-purin-6-amine 9H-Purin-6-amine, 9-cyclohexyl-N,N-dimethyl- | ||
| 9 | 723753-82-0 | 1-BUTYL-N-(4-METHYLBENZYL)-1H-TETRAZOL-5-AMINE | 1-BUTYL-N-(4-METHYLBENZYL)-1H-TETRAZOL-5-AMINE | ||
| 10 | 880865-59-8 | 1-butyl-N-(2-methylbenzyl)-1H-tetraazol-5-amine | 1-butyl-N-(2-methylbenzyl)-1H-tetraazol-5-amine | ||
| 11 | N-(4-(DIETHYLAMINO)BENZYL)-1H-1,2,4-TRIAZOL-3-AMINE | N-(4-(DIETHYLAMINO)BENZYL)-1H-1,2,4-TRIAZOL-3-AMINE ZERENEX E/6027576 | |||
| 12 | 67026-47-5 | 2-Cyano-1-(1,2-dimethylbutyl)-3-(4-pyridyl)guanidine | 2-Cyano-1-(1,2-dimethylbutyl)-3-(4-pyridyl)guanidine Guanidine, N-cyano-N'-(1,2-dimethylbutyl)-N''-4-pyridinyl- | ||
| 13 | N-(4-ethylbenzyl)-N-(1-propyl-1H-tetraazol-5-yl)amine | N-(4-ethylbenzyl)-N-(1-propyl-1H-tetraazol-5-yl)amine | |||
| 14 | N-(2-methylpentyl)-4-(1H-1,2,3,4-tetrazol-1-yl)aniline | N-(2-methylpentyl)-4-(1H-1,2,3,4-tetrazol-1-yl)aniline | |||
| 15 | 60560-40-9 | 2-Cyano-3-(4-pyridyl)-1-(1,1,2-trimethylpropyl)guanidine | 2-Cyano-3-(4-pyridyl)-1-(1,1,2-trimethylpropyl)guanidine Guanidine, N-cyano-N'-4-pyridinyl-N''-(1,1,2-trimethylpropyl)- | ||
| 16 | butyl({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | butyl({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | |||
| 17 | N-(3-methylpentan-2-yl)-4-(1H-1,2,3,4-tetrazol-1-yl)aniline | N-(3-methylpentan-2-yl)-4-(1H-1,2,3,4-tetrazol-1-yl)aniline | |||
| 18 | 2-Cyano-3-(4-pyridyl)-1-[(R)-1,2,2-trimethylpropyl]guanidine | 2-Cyano-3-(4-pyridyl)-1-[(R)-1,2,2-trimethylpropyl]guanidine N-Cyano-N'-(4-pyridinyl)-N''-[(R)-1,2,2-trimethylpropyl]guanidine | |||
| 19 | butan-2-yl({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | butan-2-yl({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | |||
| 20 | N''-Cyano-N-(3-pyridyl)-N'-[(S)-1,2,2-trimethylpropyl]guanidine | N''-Cyano-N-(3-pyridyl)-N'-[(S)-1,2,2-trimethylpropyl]guanidine | |||
| 21 | N-Cyano-N'-(4-pyridinyl)-N''-[(S)-1,2,2-trimethylpropyl]guanidine | N-Cyano-N'-(4-pyridinyl)-N''-[(S)-1,2,2-trimethylpropyl]guanidine | |||
| 22 | (2-methylpropyl)({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | (2-methylpropyl)({1-[3-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl})amine | |||
| 23 | 575461-46-0 | 4,6-Dimethyl-N-(octahydro-2H-benzimidazol-2-ylidene)pyrimidin-2-amine | ST5024159 SMR000074172 MLS000099506 BAS 06575968 4,6-Dimethyl-N-(octahydro-2H-benzimidazol-2-ylidene)pyrimidin-2-amine N-(4,6-dimethyl-2-pyrimidinyl)-3a,4,5,6,7,7a-hexahydro-1H-benzimidazol-2-amine 3a,4,5,6,7,7a-hexahydro-1H-benzimidazol-2-yl-(4,6-dimethylpyrimidin-2-yl)amine | ||
| 24 | 1-methyl-N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}piperidin-4-amine | 1-methyl-N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}piperidin-4-amine | |||
| 25 | 2612339-47-4 | 1,4-Cyclohexanediamine, N1-methyl-N1-7H-pyrrolo[2,3-d]pyrimidin-4-yl-, trans- | 1,4-Cyclohexanediamine, N1-methyl-N1-7H-pyrrolo[2,3-d]pyrimidin-4-yl-, trans- (1r,4r)-N1-methyl-N1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclohexane-1,4-diamine | ||
| 26 | 477600-74-1 | N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | Tofacitinib-11 Tofacitinib N-Descyanoacetyl (3R,4R)-N,4-diMethyl-N-{7H-pyrrolo[2,3-d]pyriMidin-4-yl}piperidin-3-aMine N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-3-piperidinyl]- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine N-Methyl-N-((3R,4R)-4-Methyl-piperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7HMethylpiperidin-3-yl)-7Hpyrrolo[2,3-d]pyriMidin-4-aMine | ||
| 27 | 2378663-15-9 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-3-piperidinyl]- | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-3-piperidinyl]- Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) Tofacitinib Impurity 70 | ||
| 28 | N-(3a,4,5,6,7,7a-hexahydro-1H-benzimidazol-2-yl)-N-(4,6-dimethyl-2-pyrimidinyl)amine | N-(3a,4,5,6,7,7a-hexahydro-1H-benzimidazol-2-yl)-N-(4,6-dimethyl-2-pyrimidinyl)amine |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|